Arthur Przybyl - Net Worth and Insider Trading

Arthur Przybyl Net Worth

The estimated net worth of Arthur Przybyl is at least $12 Million dollars as of 2024-05-24. Arthur Przybyl is the President and CEO of ANI Pharmaceuticals Inc and owns about 202,589 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $12 Million. Details can be seen in Arthur Przybyl's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arthur Przybyl has not made any transactions after 2019-05-15 and currently still holds the listed stock(s).

Transaction Summary of Arthur Przybyl

To

Arthur Przybyl Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arthur Przybyl owns 2 companies in total, including ANI Pharmaceuticals Inc (ANIP) , and Akorn Inc (AKRXQ) .

Click here to see the complete history of Arthur Przybyl’s form 4 insider trades.

Insider Ownership Summary of Arthur Przybyl

Ticker Comapny Transaction Date Type of Owner
ANIP ANI Pharmaceuticals Inc 2019-05-15 director & President and CEO
AKRXQ Akorn Inc 2008-12-31 director & President & CEO

Arthur Przybyl Latest Holdings Summary

Arthur Przybyl currently owns a total of 1 stock. Arthur Przybyl owns 202,589 shares of ANI Pharmaceuticals Inc (ANIP) as of May 15, 2019, with a value of $12 Million.

Latest Holdings of Arthur Przybyl

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANIP ANI Pharmaceuticals Inc 2019-05-15 202,589 60.36 12,228,272

Holding Weightings of Arthur Przybyl


Arthur Przybyl Form 4 Trading Tracker

According to the SEC Form 4 filings, Arthur Przybyl has made a total of 0 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 30,000 shares on May 15, 2019, which brought Arthur Przybyl around $2 Million.

Insider Trading History of Arthur Przybyl

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arthur Przybyl Trading Performance

GuruFocus tracks the stock performance after each of Arthur Przybyl's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur Przybyl is -28.07%. GuruFocus also compares Arthur Przybyl's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur Przybyl within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Arthur Przybyl's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Arthur Przybyl

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.65
Relative Return to S&P 500(%) 7.29

Arthur Przybyl Ownership Network

Ownership Network List of Arthur Przybyl

No Data

Ownership Network Relation of Arthur Przybyl


Arthur Przybyl Owned Company Details

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Arthur Przybyl is the director & President and CEO of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include HEAD OF RARE DISEASE Christopher Mutz , director & HEAD OF R&D & COO-NOVITIUM OPS Muthusamy Shanmugam , and director & PRESIDENT & CEO Nikhil Lalwani .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Arthur Przybyl made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 676,190 shares made by Muthusamy Shanmugam , a net sale of 160,000 shares made by Chad Gassert , and a net sale of 1,750 shares made by Meredith Cook .

In summary, during the past 3 months, insiders sold 320,801 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 320,801 shares. During the past 18 months, 1,462,027 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,462,027 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

Arthur Przybyl Mailing Address

Above is the net worth, insider trading, and ownership report for Arthur Przybyl. Currently GuruFocus does not have mailing address information for Arthur Przybyl.

Discussions on Arthur Przybyl

No discussions yet.